XACTACEL Trademark

Trademark Overview

On Wednesday, June 17, 2015, a trademark application was filed for XACTACEL with the United States Patent and Trademark Office. The USPTO has given the XACTACEL trademark a serial number of 79172184. The federal status of this trademark filing is CANCELLED - SECTION 71 as of Friday, September 30, 2022. This trademark is owned by NOVARTIS AG. The XACTACEL trademark is filed in the Medical & Beauty Services & Agricultural Services category with the following description:

Medical services, namely, in the field of gene and cellular immunotherapies and transplantation and medical diagnostic testing, monitoring and reporting services; medical treatment services in the field of oncology; blood testing, and blood treatment and processing for the purpose of medical clinical diagnosis; consulting services in the fields of medical treatment and medicines, medical diagnostic testing, and diagnostic and clinical blood treatment procedures; human biological cell banking services, namely, the collection, preservation, and storage of human biological tissue; collection and preservation of human blood and cells for medical use; providing medical information, namely, hosting a patient support call center regarding gene and cellular immunotherapies and transplantation
xactacel

General Information

Serial Number79172184
Word MarkXACTACEL
Filing DateWednesday, June 17, 2015
Status709 - CANCELLED - SECTION 71
Status DateFriday, September 30, 2022
Registration Number4916249
Registration DateTuesday, March 15, 2016
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 29, 2015

Trademark Statements

Translation of Words in MarkThe wording "XACTACEL" has no meaning in a foreign language.
Goods and ServicesMedical services, namely, in the field of gene and cellular immunotherapies and transplantation and medical diagnostic testing, monitoring and reporting services; medical treatment services in the field of oncology; blood testing, and blood treatment and processing for the purpose of medical clinical diagnosis; consulting services in the fields of medical treatment and medicines, medical diagnostic testing, and diagnostic and clinical blood treatment procedures; human biological cell banking services, namely, the collection, preservation, and storage of human biological tissue; collection and preservation of human blood and cells for medical use; providing medical information, namely, hosting a patient support call center regarding gene and cellular immunotherapies and transplantation

Classification Information

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, September 30, 2022
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameNOVARTIS AG
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressCH
Party NameNOVARTIS AG
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressCH
Party NameNOVARTIS AG
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressCH

Trademark Events

Event DateEvent Description
Tuesday, July 25, 2023TOTAL INVALIDATION PROCESSED BY THE IB
Thursday, June 29, 2023TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Thursday, June 29, 2023INVALIDATION PROCESSED
Tuesday, May 30, 2023TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Friday, September 30, 2022CANCELLED SECTION 71
Monday, March 15, 2021COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Saturday, July 9, 2016FINAL DECISION TRANSACTION PROCESSED BY IB
Thursday, June 16, 2016FINAL DISPOSITION NOTICE SENT TO IB
Thursday, June 16, 2016FINAL DISPOSITION PROCESSED
Wednesday, June 15, 2016FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, March 15, 2016REGISTERED-PRINCIPAL REGISTER
Monday, January 4, 2016NOTIFICATION PROCESSED BY IB
Tuesday, December 29, 2015OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 29, 2015PUBLISHED FOR OPPOSITION
Wednesday, December 16, 2015NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, December 16, 2015NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, December 9, 2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, October 29, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, October 29, 2015EXAMINER'S AMENDMENT ENTERED
Thursday, October 29, 2015NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, October 29, 2015EXAMINERS AMENDMENT E-MAILED
Thursday, October 29, 2015EXAMINERS AMENDMENT -WRITTEN
Friday, October 9, 2015REFUSAL PROCESSED BY IB
Friday, September 25, 2015ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, September 25, 2015TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, September 22, 2015NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Monday, September 21, 2015REFUSAL PROCESSED BY MPU
Saturday, September 19, 2015NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Friday, September 18, 2015NON-FINAL ACTION WRITTEN
Friday, September 18, 2015APPLICATION FILING RECEIPT MAILED
Wednesday, September 16, 2015ASSIGNED TO EXAMINER
Monday, September 14, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, September 10, 2015SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

xactacel medical services blood treatment diagnostic human namely testing preservation clinical